AVEO Pharmaceuticals CEO Michael Bailey's 2018 pay jumps 127% to $3.1M
AVEO Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
AVEO Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, five executives at AVEO Pharmaceuticals received on average a compensation package of $1.6M, a 44% increase compared to previous year.
Average pay of disclosed executives at AVEO Pharmaceuticals
Michael Bailey, Chief Executive Officer, received $3.1M in total, which increased by 127% compared to 2017. 75% of Bailey's compensation, or $2.3M, was in option awards. Bailey also received $174K in non-equity incentive plan, $528K in salary, as well as $68K in other compensation.
For fiscal year 2018, the median employee pay was $248,144 at AVEO Pharmaceuticals. Therefore, the ratio of Michael Bailey's pay to the median employee pay was 13 to one.
Matthew Dallas, Chief Financial Officer, received a compensation package of $1.3M, which increased by 29% compared to previous year. 66% of the compensation package, or $879K, was in option awards.
Nikhil Mehta, Sr. Vice President, Regulatory and Quality Assurance, earned $1.3M in 2018, a 12% increase compared to previous year.
Michael Needle, Chief Medical Officer, received $1.1M in 2018, which increases by 36% compared to 2017.
Karuna Rubin, General Counsel, earned $1M in 2018.
Related executives
Michael Bailey
AVEO Pharmaceuticals
Chief Executive Officer
Matthew Dallas
AVEO Pharmaceuticals
Chief Financial Officer
Michael Needle
AVEO Pharmaceuticals
Chief Medical Officer
Nikhil Mehta
AVEO Pharmaceuticals
Sr. Vice President, Regulatory and Quality Assurance
Karuna Rubin
AVEO Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on April 30, 2019.